Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
05/2014
05/28/2014CN102757435B 一种反式-3-吲哚基-4-吲哚并二氮杂卓环庚烷基-2,5-吡咯烷-2,5-二酮化合物及其制备方法 An anti-3-indol-4-indolo diazepino cycloheptyl group 2,5-2,5-dione compounds and methods
05/28/2014CN102716340B 一种用于治疗食管癌的中药 A Chinese medicine for the treatment of esophageal cancer
05/28/2014CN102670625B 一种脲类化合物的应用 Application of a urea compound
05/28/2014CN102603743B 抗肿瘤的氮杂苯并[f]薁衍生物其制备方法及其用途 Aza-benzo antineoplastic [f] azulene derivatives their preparation and use thereof
05/28/2014CN102584780B 一种蓝萼甲素衍生物及其制备方法和应用 One kind glaucocalyxin A derivative and its preparation method and application
05/28/2014CN102516392B 一种癌靶向超抗原融合蛋白及制备方法及用途 In a cancer-targeted superantigen fusion protein and preparation method and uses
05/28/2014CN102492038B 抗人Tim-3的中和性单克隆抗体L3D及其用途 Tim-3 anti-human neutralizing monoclonal antibodies and their use L3D
05/28/2014CN102458428B Nfat信号抑制剂和钙调磷酸酶抑制剂 Nfat signaling inhibitors and calcineurin inhibitors
05/28/2014CN102382065B 苯胺取代的喹唑啉衍生物 Anilino substituted quinazoline derivatives
05/28/2014CN102311460B 一种羰基锝标记的苯丁酸氮芥配合物及其制备方法与用途 One kind of technetium-labeled carbonyl complexes of chlorambucil and its preparation method and uses
05/28/2014CN102311442B 具有抗肿瘤活性的螺内酰胺生物碱化合物及其制备方法与应用 Lo lactam alkaloid compound and its preparation method and application has anti-tumor activity
05/28/2014CN102285979B N-(2-(取代苯并噻唑-2-氨基甲酰基)-苯基)-取代吡唑甲酰胺类化合物及其制备方法和用途 N- (2- (substituted benzothiazole-2-carbamoyl) - phenyl) - substituted pyrazole carboxamides and their preparation and use
05/28/2014CN102264742B 3-(3-嘧啶-2-基苄基)-1,2,4-三唑并[4,3-b]哒嗪衍生物 3- (3-pyrimidin-2-yl) -1,2,4-triazolo [4,3-b] pyridazine derivatives
05/28/2014CN102250210B 人纤溶酶原Kringle 5短肽、其药物组合物、用途和编码该种短肽的多核苷酸 Human plasminogen Kringle 5 peptide, pharmaceutical compositions, uses and types of short peptides encoding the polynucleotide
05/28/2014CN102247355B 几内亚胡椒碱的抗肿瘤用途 Guinea piperine antitumor use
05/28/2014CN102227429B 作为趋化因子受体调节剂的3-氨基环戊烷羧酰胺 As chemokine receptor modulators of 3-amino-cyclopentane-carboxamide
05/28/2014CN102164962B 抗gd2抗体和方法及其相关应用 Antibodies and anti gd2 method and related applications
05/28/2014CN102083429B Ido抑制剂 Ido inhibitor
05/28/2014CN102078305B 苯达莫司汀冻干药物组合物 Bendamustine lyophilized pharmaceutical composition
05/28/2014CN102015676B 作为amp-活化的蛋白激酶(ampk)活化剂的噻吩并吡啶酮衍生物 Thiophene amp- activated protein kinase (ampk) activator and pyridone derivative
05/28/2014CN102014632B 吲哚啉抗癌剂 Indoline anticancer
05/28/2014CN101932325B Ido抑制剂 Ido inhibitor
05/28/2014CN101898985B Bcl-2蛋白的N-取代苯磺酰基-取代苯甲酰胺类小分子抑制剂及其应用 N- Bcl-2 protein was substituted phenylsulfonyl - substituted benzamides small molecule inhibitors and their applications
05/28/2014CN101821269B 2-((r)-2-甲基吡咯烷-2-基)-1h-苯并咪唑-4-甲酰胺晶形2 2 - ((r) -2- methyl-pyrrolidin-2-yl) -1h- benzimidazole-4-carboxamide crystalline form 2
05/28/2014CN101810608B 一种靶向于人磷脂酰乙醇胺结合蛋白4的抗肿瘤小分子化合物 A targeted to people phosphatidylethanolamine binding protein antitumor small molecule compounds 4
05/28/2014CN101642452B 脑肿瘤用放射线敏化剂 Brain tumors with a radiation sensitizer
05/28/2014CN101535300B Iap bir域结合化合物 Iap bir domain binding compound
05/27/2014US8735401 Thienopyrimidine compounds and use thereof
05/27/2014US8735387 Oxazolopyrimidines as Edg-1 receptor agonists
05/27/2014US8735375 Therapeutic compositions
05/27/2014US8735357 Method of inducing antigen-specific T cells
05/27/2014US8735355 Methods of use of fragments of secreted frizzled related protein, sFRP
05/27/2014US8735342 Method for treating brain cancer using a novel tumor suppressor gene and secreted factor
05/27/2014US8734800 Subtypes of humanized antibody against interleukin-6 receptor
05/27/2014US8734792 Reagents and treatment methods for autoimmune diseases
05/27/2014CA2758986C Inhibitors of pi3 kinase and/or mtor
05/27/2014CA2752738C Small molecule inhibitors of mdm2 and uses thereof
05/27/2014CA2647803C Combination comprising a) a pyrimidylaminobenzamide compound, and b) a thr315lle kinase inhibitor
05/27/2014CA2631876C Aminophenyl derivatives as inhibitors of histone deacetylase
05/27/2014CA2629132C Pyrimidylaminobenzamide derivatives for the treatment of neurofibromatosis
05/27/2014CA2624829C Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
05/27/2014CA2623770C Pyridopyrimidinone inhibitors of pi3k.alpha.
05/27/2014CA2622352C Substituted pyrazole compounds
05/27/2014CA2604805C Pyrrolobenzodiazepines
05/27/2014CA2597255C Natural ligand of g protein coupled receptor rcc356 and uses thereof
05/27/2014CA2540272C Preventive or ameliorating agent for liver diseases associated with hepatopathy
05/27/2014CA2497552C Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy
05/27/2014CA2481719C Modified cea nucleic acid and expression vectors
05/27/2014CA2442080C A preparation for restenosis prevention
05/27/2014CA2406033C Anti-d monoclonal antibodies
05/27/2014CA2371814C Trpm-2 antisense therapy
05/22/2014WO2014078686A1 Mirnas as novel therapeutic adjuvants and biomarkers for the prognosis and treatment of drug resistant breast cancers
05/22/2014WO2014078645A1 Heterocyclic glutaminase inhibitors
05/22/2014WO2014078637A1 Novel heterocyclic derivatives as modulators of kinase activity
05/22/2014WO2014078634A1 Novel imidazol-piperidinyl derivatives as modulators of kinase activity
05/22/2014WO2014078633A1 Methods for treating cancers having brca2 and palb2 mutations
05/22/2014WO2014078578A1 Pyrrolopyrimidine compounds as kinase inhibitors
05/22/2014WO2014078529A1 Oncolytic hsv1 vectors and methods of using the same
05/22/2014WO2014078503A1 Methods of treating ovarian cancer with dll4 antagonists
05/22/2014WO2014078484A1 Conjugates for treating diseases caused by psma expressing cells
05/22/2014WO2014078408A1 Bicyclic heteroaryl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
05/22/2014WO2014078383A1 Inhibition of drug resistant cancer cells
05/22/2014WO2014078378A1 Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
05/22/2014WO2014078372A1 Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
05/22/2014WO2014078331A1 N-(arylalkyl)-n'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
05/22/2014WO2014078328A1 N-bicyclic aryl,n'-pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
05/22/2014WO2014078325A1 N-(monocyclic aryl),n'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
05/22/2014WO2014078323A1 N-pyrrolidinyl, n'-pyrazolyl- urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
05/22/2014WO2014078272A1 Methods and materials for assessing immune system profiles
05/22/2014WO2014078081A1 Cross-linked collagen comprising metallic anticancer agents
05/22/2014WO2014077915A1 Methods and materials for identifying malignant skin lesions
05/22/2014WO2014077784A1 Method of treating cancer
05/22/2014WO2014077668A1 Combination of molecular iodine and anthracyclines for human use for the prevention and treatment of iodine-capturing chemically-resistant cancers
05/22/2014WO2014077648A1 Antibody binding specifically to human and mouse l1cam protein, and use therefor
05/22/2014WO2014077438A1 Composition containing pharbitidis semen extract for pancreatic cancer treatment and functional food
05/22/2014WO2014077437A1 Composition containing pharbitidis semen extract for renal cancer treatment and functional food
05/22/2014WO2014077436A1 Composition containing inulae radix extract for pancreatic cancer treatment and cosmetics
05/22/2014WO2014077435A1 Composition containing inulae radix extract for renal cancer treatment cosmetics
05/22/2014WO2014077434A1 Composition containing gleditsiae semen extract for pancreatic cancer treatment and functional food
05/22/2014WO2014077433A1 Composition containing gleditsiae semen extract for renal cancer treatment and functional food
05/22/2014WO2014077432A1 Composition containing rubiae radix extract for renal cancer treatment and cosmetics
05/22/2014WO2014077409A1 Agent for mitigating side effect of sunitinib
05/22/2014WO2014077289A1 Anticancer agent
05/22/2014WO2014076703A1 Methods and compositions for treating cancer
05/22/2014WO2014076292A1 Recombinant bispecific antibody binding to cd20 and cd95
05/22/2014WO2014076237A1 Triazolopyrazine
05/22/2014WO2014076162A1 Aminoimidazopyridazines
05/22/2014WO2014076111A1 N-(pyridin-2-yl)pyrimidin-4-amine derivatives containing a sulfoximine group
05/22/2014WO2014076091A1 5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group
05/22/2014WO2014076028A1 4-(ortho)-fluorophenyl-5-fluoropyrimidin-2-yl amines containing a sulfoximine group
05/22/2014WO2014075754A1 3-aminocyclopentane carboxamide derivatives
05/22/2014WO2014075631A1 Method for preparing autologous tumor vaccine and use thereof
05/22/2014WO2014075583A1 Stable oral solid drug composition of abiraterone and preparation method therefor
05/22/2014WO2014075576A1 Humanized anti-human epidemic growth factor receptor antibody and encoding gene and application thereof
05/22/2014WO2014075575A1 Pyrrole sulfonamide derivative, preparation method for same, and medical application thereof
05/22/2014WO2014075574A1 A method of using binuclear gold(i) compounds for cancer treatment
05/22/2014WO2014075554A1 Pharmaceutical composition containing sirolimus esterification and preparation method thereof
05/22/2014WO2014075394A1 Novel gold(iii) complexes containing n-heterocyclic carbene ligand, synthesis, and their applications in cancer treatment and thiol detection
05/22/2014WO2014075393A1 Purine inhibitors of human phosphatidylinositol 3-kinase delta
05/22/2014WO2014075392A1 Purine inhibitors of human phosphatidylinositol 3-kinase delta
1 ... 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 ... 2211